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1. Introduction 
Bioactive peptides play critical roles in regulating most biological processes in animals, and 
they have considerable biological, medical and industrial importance. Peptides belonging to 
the same family are often characterized by a typical short sequence motif (pattern) that is 
highly functionally preserved among the family members. In this chapter, we design a 
pattern search method to facilitate the detection of such conserved motifs. First, all known 
bioactive peptides annotated in Uniprot are collected and classified, and the program Pratt 
is used to search these unaligned peptide sequences in each family for conserved patterns. 
The obtained patterns are then refined by taking into account the information on amino 
acids at important functional sites collected from literature, and are further tested by 
scanning them against all the Uniprot proteins. The diagnostic power of the patterns is 
demonstrated by the fact that, while the false positive is kept to zero to ensure that the 
signatures are exclusive to peptides and their precursors, nearly 94% of all known peptide 
family members accommodate one or several of the identified patterns.  
In total, we brought to light 155 novel peptide patterns in addition to the 56 established ones 
in the PROSITE database. All the patterns represent 110 peptide families; among which 55 
are not characterized by PROSITE and 12 are also dismissed by other existing motif 
databases, such as Pfam. Using the newly uncovered peptide patterns as a search tool, we 
predicted 95 hypothetical proteins as putative peptides or peptide precursors. 
2. Problem statement and background 
Whole genome sequencing projects have made available immense sequence data at a pace 
that far supersedes their rate of annotation. As a result, out of 1.7 million protein sequences, 
which are currently available for all the completely sequenced metazoan genomes, nearly 
15% could not be assigned to any putative function. Although several tools/algorithms are 
available to contribute towards the putative functional assignments of the proteins, yet large 
numbers of proteins remain un-elucidated. In most cases this is due to the low degrees of 
sequence similarities with known proteins; alternatively, the existing similarities can be 
confined to only very small part(s) of the entire protein. The latter is especially true for 
precursor proteins coding for bioactive peptides. Consequently, there is still a need for 
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bioinformatic tools to predict the function of the enormously large number of the unknown 
protein sequences. 
Bioactive peptides occur in the whole animal kingdom, from the least evolved phyla to the 
highest vertebrates (Filipsson et al., 2001; Masashi et al., 2001). They play key roles as 
signaling molecules in many, if not all physiological processes, for instance as a peptidergic 
neurotransmitter or neurohormone, as a peptidergic toxin, or as a growth factor (Boonen et 
al., 2007; Boonen et al., 2010). They are synthesized in the cell in the form of large 
preproproteins (precursors), which are a special class of proteins as they undergo extensive 
post-translational processing prior to producing final mature bioactive peptides (Schoofs & 
Baggerman, 2003). Peptides and their precursors that are structurally and functionally 
related have been classified into peptide families; each family of proteins is assumed to be 
derived from a common ancestor (Husson et al., 2009). During the evolutionary process, the 
protein sequences may have much diverged, but the essential amino acids involved in the 
biologically important activities are still present. These conserved amino acids along with 
their particular sequential order form the functional foundation and represent the motif 
(pattern) of a peptide family. 
However, over the course of natural adaptation, different peptide families have diverged at 
different rates. While for some peptide families, the similarity extends over a much longer 
region even over the entire peptide precursor sequences; for many others, a short highly 
conserved motif is responsible for the function of the precursor proteins throughout the 
family members, and the sequence fragments outside the conserved regions often display no 
significant similarities (Baggerman et al., 2005). The latter conserved sequence characteristics 
can be further exposed by many short but biologically important functional peptides 
released from known large precursors as annotated in Uniprot, such as the 3-amino-acid 
thyroliberin peptide ‘QHPamide’ (Vandenborne et al., 2005) and 4-amino-acid 
neuropeptides ‘FMRFamide’ (Baggerman et al., 2002). For some mature peptides, the 
precursor proteins (genes) are unknown, such as the 2-amino-acid neuropeptide ‘GWamide’ 
(P83570) from Sepia officinalis (Henry et al., 1997) and the human growth-modulating 
peptide ‘GHK’ (P01157) (Schlesinger et al., 1977). The existence of numerous short bioactive 
peptides within the precursor proteins implies that only a very small conserved peptide 
motif may be a biologically important functional portion of the precursors.  
Due to the fact that only short sequence regions are conserved, peptides or their precursors 
are sometimes not identified by existing sequence alignment algorithms e.g. BLAST or by 
motif search methods. While BLAST programs (Altschul et al., 1997) are very suitable to 
scan databases for homologous proteins, they are far less efficient at finding similarities to 
short conserved regions which can be only a few amino acids in length, when the whole 
genome sequence is scanned. For large precursors which are usually a few hundred amino 
acids in length and for which the biologically conserved regions are limited, the important 
domains are often masked by long randomly unrelated sequence regions. This is because for 
any two random large protein sequences, BLAST usually can find a relative long local 
alignment, at least longer than the short conserved peptide motif, and BLAST tends to 
assign a higher score to a longer alignment (Durbin et al., 1998). In addition, if a pair of 
homologues involves a short independent peptide molecule, which may be either an 
unknown peptide sequence as query or a known mature peptide as target from a protein 
database, it is difficult for BLAST to detect the pair of homologues, because the involvement 
of a short sequence makes the pairwise sequence alignment less likely to obtain a significant 
BLAST score (e.g., e-value < 0.01).  
www.intechopen.com
 
A Pattern Search Method for Discovering Conserved Motifs in Bioactive Peptide Families 
 
123 
Like BLAST, motif search methods are important tools to search for a protein in a database, 
nevertheless, they are also limited to detect all members from a characterized peptide 
family. Most of the motifs in the existing databases, e.g. PROSITE (Hulo et al., 2004) and 
Pfam (Finn et al, 2010), cover the entire precursor sequences or sequence domains which are 
much longer than the conserved bioactive peptide regions. Therefore, the database motifs 
show their weakness when they are used to detect short mature peptides for which the 
precursors are unknown and the information on the sequences outside the peptide regions 
is thus missing. In addition, the construction of these motifs requires a good multiple 
protein sequence alignment in order to produce an accurate signature. This works well 
when the sequences are easy to align. However, for some peptide families for which the 
conserved regions are very short and the bulk of peptide precursor sequences is not very 
well preserved, the multiple alignment is very difficult to obtain or evaluate. The overall 
precursor protein sequence identity, especially in distantly related homologues, may be too 
low for an accurate alignment. In some cases, the short conserved regions are repeated 
within a precursor, making it even more challenging to build a unique alignment that truly 
reflects the evolutionary relationship. 
In this chapter, we have followed an alternative approach, taking unaligned sequences as a 
starting point. We then used a pattern search program to look for conserved patterns. We 
first collected all currently annotated peptides and peptide precursor proteins in Metazoa 
through a search in Uniprot and classified them into peptide families. Next, we extracted 
peptide sequences in each family and used the program Pratt to search the sequences for 
representative patterns. Such patterns consist of highly conserved positions that can be 
separated by fixed or variable spacing. The patterns are then refined by incorporating the 
information that is available in literature on the important amino acids contained within the 
biologically active site(s) of the peptides. The specificity of the generated patterns are further 
verified by scanning them against Uniprot in order to ascertain that proteins picked up by 
the patterns are either annotated as peptides or peptide precursor proteins or have an 
unknown function. 
3. Data collection 
3.1 Peptide precursor collection and classification 
A protein was collected into a peptide-precursor database if it is annotated in the Uniprot 
protein database (release 6.6) consisting of Swiss-Prot (release 48.6) and TrEMBL (release 
31.6) with one of the following keywords: hormone, antimicrobial, toxin. The hormone 
includes bombesin, bradykinin, cytokine, glucagon, growth factor, hormone, hypotensive 
agent, insulin, neuropeptide, neurotransmitter, opioid peptide, pyrokinin, tachykinin, 
thyroid hormone, vasoactive, vasoconstrictor and vasodilator (the definition of the 
keywords can be referred to in this database). The antimicrobial consists of antibiotic, 
antiviral defense, defensin and fungicide; while the toxin includes naturally produced and 
secreted poisonous proteins that damage or kill other cells. However, when the protein is 
also characterized by non-peptide keywords, such as receptor, signal-anchor, 
transmembrane, binding protein, DNA binding, nuclear protein, transport, collagen, 
enzyme or words ending in ‘ase’ (excluding ‘disease’), it is excluded, in order to avoid the 
selection of proteins which are not peptides or peptide precursors. 
Stand-alone PSI-BLAST (ftp://ftp.ncbi.nih.gov/blast/executables/) is then used to align all 
the assembled sequences with all the Uniprot proteins except the ones which are already in 
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the peptide-precursor database. Based on the conserved sequence characteristics of peptide 
families, the score matrix PAM30 is used and the word size is set to 2, allowing for the 
search for short but strong similarities. The proteins, which show significant similarities (e-
value <0.01) with the known peptides or precursors, are retained. The obtained list is then 
checked manually in terms of the proteins’ cellular location, molecular function and 
biological process as stated by GO (gene ontology) terms or in literature. As a result, 1345 
more proteins which have as yet not been annotated in Uniprot are added to the peptide-
precursor database. 
Proteins collected in this database are automatically classified into peptide families if their 
family classification information is available in Uniprot that is based on a significant match 
to an existing motif or based on sequence similarities. Otherwise, proteins that display 
sequence similarities with a significant BLAST score, are clustered into the same family. A 
protein can also be assigned to a particular family based on its molecular function described 
in literature. 
3.2 In silicon extraction of peptides 
From each precursor protein in a peptide family, the bioactive peptide sequences are 
extracted in silicon from the beginning and ending positions of the subsequences that are 
annotated as ‘peptide’ or ‘chain’ in ‘feature’ line in the corresponding protein file in Uniprot. 
The conserved basic cleavage sites flanking the peptides, which contribute to the 
endoproteolytic cleavage process of the peptides from their precursors, such as the 
monobasic site (G)R or (G)K, the dibasic sites (G)KR, (G)RR, (G)KK or (G)RK, or a 
combination of consecutive K or R, are also withdrawn along with the subsequences (Liu & 
Wets, 2005; Rouille et al., 1995). 
Entries in the family that only constitute the peptide sequence, i.e. in those cases where the 
precursor is unknown, are also retained. Proteins less than 200aa (amino acids) in length, 
which contain an N-terminal signal peptide and for which no mature peptides have as yet 
been identified, presumably contain a single peptide and are therefore also deposited after 
in silicon removal of the N-terminal signal peptide. According to the statistics on all 
annotated bioactive peptide sequences in Uniprot, 97% are no longer than the 200aa 
threshold value. The presence of a signal peptide is assumed when it is indicated in Uniprot; 
in other cases, it is forecasted by the signal peptide prediction program signalP 
(http://www.cbs.dtu.dk/services/SignalP/). 
In total, 110 datasets of peptide families are formed with each including at least 10 peptide 
sequences. All the extracted peptide sequences in each of the families were scanned 
independently for patterns conserved in the corresponding family. 
4. Method 
Different software available on the internet provides users the tools to search for patterns 
conserved in a set of unaligned protein sequences. Pratt (http://www.ebi.ac.uk/pratt/#) 
(Jonassen et al., 1995) is a flexible pattern search tool in the number of parameters that can 
be controlled by users. It allows searching for patterns of conserved positions with limited 
variable length spacing, which is important because even in well-conserved peptide regions, 
variable loop sizes can occur. Pratt is run on each of the peptide family datasets, and the 
searching parameters are set based on maximum pattern length and pattern flexibilities 
found in the existing peptide patterns in PROSITE. 
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For each Pratt run which starts with the minimum percentage of sequences to match the 
pattern (the parameter C%) equal to 90%, the most significant pattern, which is the one with 
the highest fitness in the Pratt output list, is retained. The obtained pattern is then refined by 
integrating the information on the important functional sites in the matched peptide 
sequences depicted in literature. The amino acids occurring at these sites are added to the 
pattern if they are absent at the corresponding sites in the pattern. 
The pattern is further verified by scanning it against all the Uniprot proteins using the 
ScanProsite tool (http://www.expasy.org/tools/scanprosite/). Two possible cases occur: 
(1) If the pattern is not contained in any known non-peptide protein, it is retained as a 
conserved peptide pattern. (2) Otherwise, if the pattern is matched by both peptide and non-
peptide proteins (further referred to as true and false positive hits, respectively), it is 
subsequently processed as follows. (2a)If the pattern does not include any wildcard region 
where any amino acid is accepted, the positions where the pattern is located in all matching 
protein sequences are checked. If the pattern exclusively occurs at the N- or C-terminus of 
the true positive hits, or if the peptide proteins are all small molecules, the pattern is 
retained with a constraint (‘<’ or ‘>’) imposed at the N- or C-terminus of the pattern to limit 
the maximum distance between the conserved pattern region and the N- or C-terminus of 
the peptide or precursor protein. If the pattern with such a restriction cannot distinguish the 
true positives from the false ones, the pattern is eliminated. (2b)Or, if the pattern has 
wildcard regions, the sequence fragments corresponding to the pattern in all the matching 
sequences are extracted and aligned. If the two groups of amino acids in a wildcard region X 
in this alignment have different physicochemical properties between the true and the false 
positive hits, the region X is replaced by the group of amino acids distinctively occurring in 
the true positive proteins. In the other case, when the two groups of amino acids share 
identical physicochemical properties, the pattern is discarded. The amino acid symbol sets: 
DE, KRH, NQ, ST, ILV, FWY, AG, C, M and P, which are classified based on the 
physiochemical nature of the side groups (Smith & Smith), are used. 
If a conserved pattern cannot be obtained, the parameter C% is reduced by 10%, and Pratt is 
re-run against the same dataset. As the percentage of sequences to match the pattern 
decreases, a pattern which is usually longer and contains more sites than the previously one 
is shown up and processed by similar refinement and verification. The procedure is 
repeated until a pattern, which represents the majority of a group of related peptide 
sequences and rules out any known non-peptide proteins, is discovered. 
Once a conserved pattern is identified in the peptide family dataset, the program ps-scan 
(ftp://ftp.expasy.org/databases/prosite/tools/ps_scan/sources/) is run locally on the 
pattern against this dataset. The sequence regions which match the pattern are removed 
from the original peptides. Each of the two remaining parts of the peptide sequences at their 
N- and C-terminus is left to form an independent sequence if it is not less than 4aa in length, 
given the assumption that the minimum length of the peptide pattern we search for is not 
less than this value. Thus, a reduced dataset is created including not only the peptides 
which are not covered by the identified pattern, but also the remaining sequences of the 
original peptides that match the pattern. This methodology is based on the fact that a 
peptide precursor protein may contain several conserved regions, and that our extracted 
peptide sequences include long peptide chains which may contain a few shorter, unrelated, 
bioactive peptides. The reduced peptide family dataset is then scanned by Pratt to discover 
the next pattern. The search procedure is repeated until the parameter C% is less than 50%. 
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This means that the remaining dataset contains no more patterns representing the majority 
of the sequences. 
Fig. 1 represents the scheme of the described pattern searching procedure which is aimed to 
examine short bioactive peptide sequences rather than their large precursor molecules, and 
to take into account not only the biologically functional sites of each individual peptide 
discussed in literature, but also the general information which is extracted by the 
computational tool Pratt from all related peptides in a family. 
5. Results 
5.1 ‘PeptideMotif’ database 
We have built a peptide-precursor database consisting of 11,688 peptides and precursor 
proteins originated from 1420 metazoan organisms; of which 11,437 proteins (98%) are 
categorized into 110 distinctive peptide families. Based on bioactive peptide sequences 
drawn from the peptide families, we uncovered in total 211 conserved patterns which are 
assembled into the peptide motif database ‘PeptideMotif’.  
All the patterns range between 4 and 52 amino acids (column) in length with 78 (37%) no 
longer than 10aa. While each of the patterns covers most of the peptides or precursors 
belonging to the corresponding family, the false positives are kept to zero because it is 
guaranteed by the criterion that a known protein matching the pattern is indeed a peptide or 
precursor protein from this family. 
5.2 Comparison with the other motif databases 
The PROSITE database (http://ca.expasy.org/prosite) is a motif database of protein families 
and domains. It consists of biologically significant sites, patterns and profiles that help to 
reliably identify to which known protein family (if any) a new sequence belongs. Its 19.9 
release contains 56 entries (patterns) describing 55 peptide families in Metazoa (the omega-
atracotoxin family has two patterns) belonging to categories of cytokines and growth 
factors, hormones and active peptides, and toxins. All the 55 families are also covered by 
patterns in the ‘PeptideMotif’ database, and these peptide patterns (Table 1) share the 
similar length to their PROSITE counterparts. However, in terms of conserved sequence 
characteristics revealed in both database motifs, more amino acids are imposed at the 
conserved sites or wildcard regions in the ‘PeptideMotif’ patterns. This is due to the fact that 
the identified peptide patterns are not only trained by running them against the Swiss-Prot 
protein database which is also used as the test dataset by PROSITE, but also against the 
TrEMBL database, in which many proteins are also annotated by keywords or literature. In 
addition, for 25 of the 56 families, we have found 34 additional novel patterns and they are 
marked as ‘new’ in Table 1. 
The remaining 121 ‘PeptideMotif’ patterns presented in Table 2 allow the identification of 55 
peptide families that are untouched by PROSITE signatures; they cover 3866 bioactive 
peptide sequences cleaved from 3572 precursors. Among the patterns, 28 representing 12 
families are also not characterized by any other motif database, such as Pfam (Bateman et 
al., 2004) and CDD (Marchler-Bauer et al., 2005). The sequence reminiscence for these 
families is short and often occurs repeatedly within a same precursor protein. The sequences 
outside the conserved region are not well preserved, and thus a probability model based on 
protein sequence alignments cannot efficiently characterize such peptide families. 
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Fig. 1. Procedure for searching patterns in peptide sequences. 
Note: The parameters are set as follows: the maximum pattern length (PL) is 52, the 
maximum length of a wildcard (PX) is 15, the maximum number of flexible wildcards (FN) 
is 3, the maximum flexibility of a flexible wild card (FL) is 8, the upper limit on the product 
of flexibilities for a pattern (FP) is 48, the minimum percentage of sequences to match the 
pattern (C%) is 90, 80, 70, 60 and 50%, respectively, and all other parameters are at default. 
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Cytokines and growth factors
(1) Granulins;  (1) C-x-D-x(2)-H-C-C-{LIVM}-x(4)-C; {42, 241, 2}; {Q616A1, Q7JKP2, Q9U362} 
(2)HBGF/FGF; (1) G-x-[LIVM]-{AGNP}-[STAGP]-{AGC}-{C}-x-{KRHNDE}-{WPC}-x-
[STAGDENKRHQ](0,1)-[AGST](0,1)-[DENA]-C-{QP}-[FYLIVM]-{C}-[EQH]-x-{P}-{C}-{LIVM}-
[DENKRHL]-{PLIVMDE}-[YHF]; (2) [GR]-[LIVM]-[LIVM]-{CWPDE}-[LIVM]-{PST}-{QLIVM}-x-
[KRDEVIAGQFYNCS]-[STAGLMHQ]-{CP}-{AGDEN}-[FY]-[LIVM]-[AGSC]-[MLIV]-[NSTDEK]-
[GAKRSTNDEQ]-[EDNKRHSTQA]-G(new); (3) G-S-[RHKQ]-[LIVM]-{CWPDE}-[LIVM]-{PST}-
{QLIVM}-x-[KRDEVIAGQFYNCS]-[STAGLMHQ]-{CP}-{AGDEN}-[FY]-[LIVM]-[AGSC]-[MLIV]-
[NSTDEK]-[GAKRSTNDEQ]-[EDNKRHSTQA]-G (new); {300,530,44}
(3) PTN/MK heparin-binding; (1) S-[DE]-C-x-[DE]-W-x-W-x(2)-C-x-P-x-[SN]-x-D-C-G-[LIVMA]-G-
x-R-E-G (identical); (2) C-[KR]-[YF]-x-[KRFY]-x(2)-W-[AGST]-x-C-[DENST] (new); {51, 84, 1} 
(4) Nerve growth factor; (1) [GSRAED]-[CR]-[KRLIVM]-G-[LIVAT]-[DE]-{C}-x(2)-[YW]-{P}-S-x-[CR]; 
(2) [SAP]-[LIVA]-C-[DEY]-[SAG]-{WM}-[STDENC]-x-W-[VE]-[AGSTNI] (new); {321, 471, 12} 
(5)Platelet-derived growth factor (PDGF); (1) P-[PSRAKQGL]-C-[LIVMFYAGST]-x(3)-[RQ]-C-
[AGSTMLIVN]-G-S(0,1)-[CN]-C; {158, 158, 23} 
(6)Small cytokines C-x-C; (1) C-x-C-{CFYW}-{CW}-x(3)-{P}-x(2)-{C}(8)-x(5,8)-C-x(2,3)-[EQMA]-
[LIVMTE]-[LIVMF]-x(9,14)-C-[LIVMRK]-[DENH]; {206, 206, 18}; { Q6DUZ6, Q6GLX8, Q4T8B9} 
(7) Small cytokines (intercrine/chemokine) C-C; (1) C-C-[LIVMFYSTQRKHDE]-{P}(2)-{CDE}-{C}(7)-
x(2,5)-{P}-[FYWAC]-{C}(2)-x(3,6)-C-{KM}-{C}(1,3)-[SAG]-[LIVMTS]-[LIVMRTDE]-[FYLIVDE]-
{C}(7,10)-C-[STAGVILM]; {234, 234,27}; { Q3ZBN3, Q32L58} 
(8)TGF-beta; (1) [WFYSTKRHL]-[LIVM]-[LIVMKRHF]-{CPNL}-P-{FY}-{PCW}-[FYILVA]-{C}-
{QCWKRH}-{PA}-{PAGC}-C-{C}-[GE]-{C}-C; {766, 766, 59}
(9)interferon alpha, beta and delta; (1) [FYH]-[FY]-{CP}-[GNRKCDSTI]-[LIVM]-{W}-{AGC}-
[KRN](0,1)-[FYLVIMN]-L-{PAG}-{C}-{PST}-{PFYW}-[FYHDEN]-x-{QY}-[CYQE]-[AT]-W; (2) L-
{QKR}-x(0,4)-[GAEDVI]-[LVI]-[QHNDEFY]-[RQ]-[QH]-[LMIV]-[DENQVSTR]-x-L-[DENKRQ]-x-C-
[LIVMKRQG] (new); {272, 442, 29} 
(10)Granulocyte-macrophage colony-stimulating factor; (1) C-P-[LP]-T-{ST}-E-x-{QLIVMT}-C; {25, 
25, 1}; {Q4G094} 
(11) Interleukin-1; (1) [LIVSTNDEFH]-[YESTMVIR]-[LFC]-{AGCFYL}-[SA]-[ASLV]-{CFY}-
[CFYWH]-[PKRST]-{FYLC}-[WHLIVM]-[FYL]-[LI]-[SCA]-[TSVG]-x(6)-[PKRHCLIVMT]-x(0,2)-
[LIVM]-[AGSTCVINDE]; {128, 128, 24}
(12) Interleukin_2; (1) [ST]-E-[LF]-x(2)-L-x-C-L-x-[EDN]-E-L; {74, 74, 14}
(13) Interleukin_4_13; (1) [LI]-x-E-[LIVM](2)-{Q}(4)-x(0,1)-[LIVM]-[TL]-x(5,7)-C-x(2)-[LMIVST]-x-
[IV]-x-[DNS]-[LIVMA]; (2) [KREV]-N-[STA]-[STED]-[DEAG]-{C}(3,4)-C-[RKT]-[AV]-x(11,17)-C 
(new); {73, 119, 4} 
(14) Interleukin_6; (1) C-x(9)-C-[FYLIVM]-x(5)-G-L-x(2)-[FY]-x(3)-L; {69, 69, 8}
(15) Interleukin_7_9; (1) N-[DAT]-[LAPS]-[SCT]-F-L-K-{AGDE}-L-L; {20, 20, 2}
(16) Interleukin_10; (1)[KQSN]-{C}(4)-C-[QYCH]-x(4)-[LIVM](2)-x-[FL]-[FYT]-[LMVRT]-x-[DERST]-
[IV]-[LMF]; {75,75,12} 
(17) LIF / OSM; (1) [PSTA]-x(4)-F-[NQ]-x-K-x(3)-[CG]-x-[LF]-L-x(2)-Y-[HK] ; {24, 24, 4}
(18) Osteopontin; (1) P-x(1,5)-[KQ]-x-[TA]-x(2)-[GA]-S-S-E-E-K; {27, 27, 0}
Hormones
(19) Adipokinetic (1) [AGC]-Q-[LVI]-[NT]-[FY]-[ST]-[PASTKR]-[AGWSDEN]-W-[AGNDEST]; (2) 
<Q-[LVI]-[NT]-[FY]-[ST]-[PASTKR]-[AGWSDEN]-W-[AGNDEST>] (new); {45, 45, 0} {Q5TTQ9} 
(20) Bombesin-like peptides (1) [HLIVMQ]-W-A-[STIVRK]-G-[SH]-[LF]-M; {42, 42, 1}
(21) Calcitonin/CGRP/IAPP (1) [KR]-R-x(0,1)-C-[SAGDNT]-[STNG]-x(0,1)-[STAGVIL]-[TS]-C-
[VMALI]-x(3)-[LYF]-x(3)-[LYFVI]; (2) <x(0,1)-C-[SAGDNT]-[STNG]-x(0,1)-[STAGVIL]-[TS]-C-
[VMALI]-x(3)-[LYF]-x(3)-[LYFVI] (new); {83, 84, 7}
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(22) Corticotropin-releasing factor (1) [KR]-R-x(0,28)-[PQASLVIG]-[STPI]-[LIVM]-S-[LIVM]-x-
[LIVMNAG]-[PST]-[LIVMFT]-x-[LIVM]-[LM]-[RN]-x(2)-[LIVMWF]; (2) <x(0,8)-[PQASLVIG]-[STPI]-
[LIVM]-S-[LIVM]-x-[LIVMNAG]-[PST]-[LIVMFT]-x-[LIVM]-[LM]-[RN]-x(2)-[LIVMWF] (new); (3) T-
R-[PQASLVIG]-[STPI]-[LIVM]-S-[LIVM]-x-[LIVMNAG]-[PST]-[LIVMFT]-x-[LIVM]-[LM]-[RN]-x(2)-
[LIVMWF] (new); {64, 64, 9}; {Q4RWF4} 
(23) Arthropod CHH/MIH/GIH neurohormones (1) [LIVM]-{C}-x(2)-C-[KR]-{FY}-[DENGRKHQ]-C-
[FY]-{C}-{AGKRC}-{C}(2)-[FYILVM]-{C}-{CP}-C; {135, 135, 5} {Q23247}
(24) Erythropoietin/thrombopoeitin (1) P-x(4)-C-D-x-R-[LIVM](2)-x-[KRH]-x(14)-C; {34, 34, 8, 0} 
(25)Granins (1){DEF}-[DE]-[SN]-L-[SAN]-[AD]-[LIMVKR]-[DE]-[AGLSTQ]-E-L; (2) [LIVM]-x-
[KHR]-C-[LIVM](2)-[ED]-[LIVM](2)-x(5)-[KRH]-[STP]-x(3)-[PST]-x(4)-C (new); (3) K-R-[STAG]-
[NDEST]-[ED]-x(2)-[DE]-[DEGA]-[QKR]-Y-[AGST]-P-Q (new); {63, 96, 5}; {Q86T07, Q4RYY8, 
Q566G8} 
(26) Galanin (1) G-W-[ST]-L-N-[ST]-[AG]-[AG]-[FY]-[LIVM]-[LIVM]-G-P; (2) <L-N-[ST]-[AG]-[AG]-
[FY]-[LIVM]-[LIVM]-G-P (new); {31, 31, 1}
(27) Gastrin/cholecystokinin (1) [FY]-x(0,2)-[GADN]-[AS](0,1)-[WH]-[MFLIV]-[DR]-F-G-[KR]-[RS]; 
(2) Y-x(0,2)-[GA]-[AS](0,1)-[WH]-[MFL]-[DR]-F> (new); {88, 102, 4}
(28)Glucagon/GIP/secretin/VIP (1) [YH]-[STAIVGD]-[DENQ]-[AGF]-[LIVMSTE]-[FY]-
{QLPAGDEKR}-[DENSTAK]-[DENSTA]-[LIVMFYG]-[RKSTDEN]-x(3)-{P}-{P}-x(2)-[AGSTLIVMQ]-
[KREQL]-[KRDENQL]-[LVFYWG]-[LIVQ]; {202, 305, 8}
(29) Glycoprotein hormones alpha chain (1) C-x-G-C-C-[FY]-S-x-A-[FY]-P-T-P; {109, 109, 4} 
(30) Glycoprotein hormones beta chain (1)C-{C}(2)-[CW]-{C}(7,9)-C-[STAGMLIVED]-G-[HFYLRS]-
C-{C}-[STA]; (2) <x(0,8)-C-[STAGMDEVLI]-G-[HFYL]-C-{CKRH}-[ST] (new); (3) <x-[CW]-{C}(7,9)-C-
[STAGDEVLIM]-G-[HFYL]-C-{C}-[ST] (new); {341, 341, 13}
(31) Gonadotropin-releasing hormones (1) Q-[HY]-[FYW]-S-x(4)-P-G-G-[KR]-R; (2) Q-[HY]-[FYW]-
S-x(4)-P-G> (new); {178, 188, 4}
(32) Insulin (1){C}(2)-[IVLMPSTAFYR]-{CNE}-x-{C}-C-C-{CPM}-{P}-{CHW}-C-[STDNEKIGQ]-{C}(2)-
{CPAG}-[LIVMFSQ]-{CD}-{CPW}-{CHDEP}-C; (2) <x(0,205)-C-G-{FYILVMQW}-{CWPSTLIVM}-
[LIVFY]-[VILMASTPH]-{AGHCFYPQW}-{CPQSW}-[LIVMRKHQWF]-{CNP}-{WCQP}-[LVIMATC]-
C-{LM}-x(0,204)> (new);{507, 877, 52} {Q32L79, Q621L6, Q61VN2, Q61GN7, Q4T1R8} 
(33) Natriuretic peptides (1) C-F-G-x(3)-[DEA]-[RH]-I-x(3)-[ST]-x(2)-G-C; {155, 155,10}
(34) Neurohypophysial hormones (1) C-[LIFY]-[LIFYV]-x-N-C-P-x-G; (2) C-x(2,6)-[CW]-G-x(4,6)-C-
[FYAGLIVM]-x(3)-[LIVFY]-C-C (new); {112, 259, 4}
(35) Neuromedin U and S (1) [FY]-[LIVMF]-[FY]-R-P-R-N-G-[KR]; (2) [FY]-[LIVMF]-[FY]-R-P-R-N> 
(new); {24, 24, 3} 
(36) Pancreatic (1) [FY]-x(2)-{LIVM}-[LIVM]-x(2)-[YK]-x(3)-[LIVMFYRHK]-x-R-[PQVH]-R-[YF]-
[GD]-[KR]-[RS]; (2) [FY]-x(3)-[LIVM]-x(2)-[YK]-x(3)-[LIVMFYRHK]-x-R-[PQVH]-R-[YF]-x(0,1)> 
(new); {118, 118, 7}
(37) Parathyroid hormone (1) [KR]-R-x-[VI]-[STAGFYN]-[EH]-x-Q-x(2)-H-[DEN]-x-[GR]; {54, 54, 3} 
(38) Pyrokinins (1) [AGHNQDEST]-{FYST}-[PQVIWFYED]-[FY]-[AGST]-P-R-[LI]-G-[KR]-R; (2) 
[AGHNQDEST]-{FYST}-[PQVIWFYED]-[FY]-[AGST]-P-R-[LI]> (new); {72, 89, 4} {Q7PTL2, Q5TV14} 
(39) Somatotropin (1) C-{KRAG}-[STNRAC]-x(2)-[LIVMFYSRNW]-x-[LIVMSTAGY]-P-x(2)-{FYW}-
x(2)-[TALIVMSHN]-x(7)-[LIVMFYP]-x(2)-{QHKR}-{KRHP}-{NW}-x-[LIVMFYR]-[LIVMSTC]-x-
[STACVLMIG]-W; (2) C-[LIVMFG]-x-[KHRSNDEQVI]-[DEN]-{CNDEPQ}-{AGLMVI}-[KRMT]-
{DENKRHPQ}-x-[STNALIVMF]-[FYLIVMKS]-[LIMVT]-x-{NDEKRH}-[LIVMATE]-[KRNEQTA]-C 
(new); (3) [ED]-K-L-L-[DE]-R-[VIA]-[IV]-x-H-[AT]-E-L (new); (4) C-F-[KRH](2)-[DEN]-[LIVMAG]-
[HKR](2)-[LIVM]-[DEQ]-[ST]-[FYLIVM]-x(0,1)> (new); {633, 1093, 45}
(40) Tachykinin (1) [AGSTQKRFY]-[SF]-[IVFYTHQ]-G-[LVIM]-M-G-[KR]-[RS]; (2) [AGSTQKRFY]-
F-[IVLMFYSHQ]-G-[LVIMS]-R-G-K-R (new); (3) <x(0,9)-F-[IVLMFYTHQ]-G-[LVIMSTAG]-[RM]> 
(new); {104, 124,6}
www.intechopen.com
 
Bioinformatics – Trends and Methodologies 
 
130 
(41)Urotensin II (1) C-F-W-K-Y-C (identical); {30, 30,1} 
(42) Endothelin (1) C-{C}-C-{C}(4)-D-{C}(2)-C-{C}(2)-[FY]-C; {50, 104, 2} 
(43) Agouti (1) C-{C}(6)-C-{C}(6)-C-C-{C}(2)-C-{C}(2)-C-{C}-C-{C}(5,6)-C-{C}-C-{C}(6,9)-C; (2) C-
{C}(6)-C-{C}(6)-C-C-{C}(2)-C-{C}(2)-C-{C}-C-{C}(5,6)-C-{C}-C-{C}(0,8)> (new); (3) C-{C}(6)-C-{C}(6)-C-
C-{C}(2)-C-{C}(2)-C> (new); (4) C-{C}(6)-C-{C}(6)-C-C-{C}(2)-C-{C}(2)-C-{C}-C-{C}(5,6)-C(0,1)> (new); 
{37, 37, 7} 
Antimicrobial 
(44) Cecropin (1) W-[KDN]-{QNDEGAKRW}-[FYGA]-K-[KRE]-[LIVM]-E-[RKHAGN]-x-[AGVI]; (2) 
[GS]-[WRKHG]-[LIVMST]-[KRST]-K-{QNDEGAKRW}-[FYGA]-K-[KRED]-[LIVM]-E-[RKHAGN]-x-
[AGVI] (new); {96, 96, 3} {Q5TWE5} 
(45) Mammalian defensins (1) C-{C}-C-{C}(3,5)-C-{C}(6)-{CP}-[GARKSTW]-x-[SC]-{C}(6,10)-C-C; (2) 
C-[PR]-x-C-x(2,5)-C-x(2)-C-[PQ]-x-C-[PQ]-x-C (new); {119, 145, 5} 
(46) Arthropod defensins (1) [CG]-x(0,1)-{C}-{CQ}-[HNSEDRY]-C-x(3)-{C}(0,1)-[GR]-{A}-x-
[GRQAY]-[GAL]-x-C-{FY}-x(3,4)-C-{C}-C; (2) [CG]-x(0,1)-{C}(2)-[HNSEDRY]-C-x(3)-{C}(0,1)-[GR]-
{A}-x-[GRQAY]-[GAL]-x-C-{FY}-x(6)-C-{C}-C (new); {103, 105, 7}; {Q6XD83} 
(47) Cathelicidins (1) Y-{LIVM}-[EDQN]-[AVI]-[LMVI]-{HKRG}-[RKHQ]-A-[LIVMA]-[DQGEN]-x-
[LIVMFY]-N-[DEQ]; {58, 58, 0} 
Toxin 
(48) Snake toxins (1) C-{CKRPL}-x(0,2)-C-[PRTFG]- {C}(5)-x(0,6)-C-C-{P}-x-[PDEN]-x-C-[NDEY]; 
{352, 352, 20} 
(49) Myotoxins (1) K-x-C-H-x-K-x(2)-H-C-x(2)-K-x(3)-C-x(8)-K-x(2)-C; {15, 15, 0} 
(50) Scorpion short toxin 1 (1) C-{C}(4,5)-C-{PC}-{CQ}-{C}-C-x(3)-{C}-{CPWA}-x(1,4)-[GASEDN]-
[KRAVISNDE]-C-[VIMQTDK]-[NG]-x(1,2)-{P}-C-[HKRDENVI]-C; {77, 77, 6} 
(51) Alpha-conotoxin (1) < x(0,35)-{C}(15)-C-C-[SHYNDE]-{C}(2,3)-C-{C}(3,7)-C-{C}(0,12)>; (2) 
<{C}(0,14)-C-C-[SHYNDE]-{C}(2,3)-C-{C}(3,7)-C-[G>]> (new); {34, 34, 1} 
(52) I-superfamily conotoxin (1) C-{C}(6)-C-{C}(5)-C-C-{C}(1,3)-C-C-{C}(2,4)-C-{C}(3,10)-C (identical); 
{37, 37,  0} 
(53) Mu-agatoxin and spider toxin SFI (1) C-{C}(2)-[DEKR]-{C}(3)-C-{C}(4,7)-C-C-{C}(2,4)-C-{C}-C-
{C}(4,15)-C-{C}-C-x(0,10)>; {36, 36, 2} 
(54) Omega-atracotoxin (ACTX) (1)C-[IT]-P-S-G-Q-P-C (identical); (2)C-C-[GE]-[ML]-T-P-x-C 
(identical); {13, 13, 0} 
(55) Ergtoxin (1) C-{C}(5)-C-x(8)-C-{C}(2)-C-C-x(9)-C-x(4)-C-{C}-C {25, 25, 0} 
Table 1. The conserved peptide patterns similar to PROSITE signatures. 
 
Cytokines and growth factors 
(1) Interferon gamma (1) [RHSG]-[KRQ]-A-[AGFYLIVM]-x-[DE]-[LIVFY]-{QPAG}-x-[VI]-[VMLIY]-
{LVIM}-x(1,4)-L-[STAGPKRLIVM]-{Q}-x(1,9)-[AGKR]-[KR]-R; (2) [RHSG]-[KRQ]-A-[AGFYLIVM]-x-
[DE]-[LIVFY]-{QPAG}-x-[VI]-[VMLIY]-{LVIM}-x(1,4)-L-S-P-x(1,7)>; {91, 91, 44} 
(2) Interleukin_3 (1) [CVLIM]-[LIVM]-P-x-[AGPST]-x(2)-[STAGDENRKH]-x(12,14)-[DE]-F-[RKQ]-
{NDEAGQST}-K-L; {20, 20, 0} 
(3) Interleukin_5 (1) [HDE]-x(2)-C-x(3)-[IVLM]-F-x-G-[LIVMST]-x(2)-L-x-[NST]; {23, 23, 1} 
(4) Interleukin_12 alpha (1) [KRHE]-[LM]-C-x(2)-[LM]-[KRHQ]-[AG]-x(3)-R-x(2)-T-x(2)-[KR]-x(3)-Y-
[LMIV]; {34, 34, 7} 
(5) Interleukin_15(1)C-{C}(4)-[LM]-{C}-C-[FY]-[LIVFYQ]-x-[DE]-[LIVM]-x(2)-[LIVM]-x(2)-[ED]; {44, 
44, 1} 
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(6) Interleukin_17 (1) [RLM]-{QKR}-[PS]-{P}-x-[LIVMFY]-{RKH}-{CP}-[AS]-x-Cx-[CHKRNDESTFY]-
x-[GRKHFY]-C-[LIVM]; {47, 47, 4} 
(7) Interleukin_18 (1) [EQ]-[SY]-S-[SL]-x(2)-[GS]-x-[FY]-L-[AST]-[CF]; {41, 41, 3} 
(8) Receptivity factor (1) L-[LIVMPAG]-x(2)-[YF]-[LIVM]-x(2)-[QLIVM]-[GA]-x-P-[LIVMFY]-x-
[DENHKRLIVM]-[PAG]-[DEAGST]-[FY]; {204, 204, 0} 
(9) GMF-beta (1) [FY]-[LIVM](2)-x-[STAG]-[FYWH]-x(5)-[DE]-x(5)-P-[LIVM]-x(2)-[LIVM]-[FYWN]-
x(2)-P; {29, 29, 1}; {Q9VJL6, Q29NM1} 
Hormones
(10) ACTH_domain and opioid neuropeptides (1) K-R-[YF]-G-G-F-[LIVMT]-[STGKRIV]-
[AGKRSTLIVMPY]; (2) K-R-[YF]-G-G-F-[LIVMT]>; (3) K-[KN]-[YF]-G-G-F-M-[KR]; (4) <[YF]-G-G-F-
[LIVMT]-[STGKRIV]-[AGKRSTLIVMPY]; (5){CFYWHM}-Y-x-[MIVSTFY]-{FY}-H-F-R-W; (6) <Y-x-
[MIVSTFY]-{FY}-H-F-R-W; {397, 1045, 4} 
(11)FMRFamide and related neuropeptides (1){LCFY}-{LCFYQWST}-{LCFYQWH}-
{LCDEFYKRQW}-[LVMI]-[MLIV]-R-F-G-K-R;(2){LCFY}-{LCFYQWSTLIVM}-{LCFYQWHKR}-
{LCDEFYKRQWLIVM}-[LM]-[MIV]-R-F-GR-[ASPD]-{LCFYHKR}-{LCQST};(3)<x(0,8)-[LVMI]-
[MLIV]-R-F>;(4){CLIVM}-{CAGLIVMW}-{QCFYLW}-[FY]-[MLIV]-R-F-G-K-R; (5){CHIV}-x-{CQN}-
{HIV}-{CLIVMY}-{CAGLIVMW}-{QCFYLWIV}-[FY]-[MLIV]-R-F-G-R-[DNESTAG];(6)<x(0,9)-[FY]-
[MLIV]-R-F>;(7)[AGED]-[LIVMFY]-Q-G-R-F-G-R-[DEN];(8)P-[AGST]-[LIVM]-R-[MLIV]-R-F>;(9)N-
Q-[VI]-R-F-G-K-R; (10) [STG]-[LVMI]-F-R-F-G-K-R; (11)[RD]-[QPH]-F-[FY]-R-F-G-[KR]-{FWYL}; 
(12)[RD]-[QPH]-F-[FY]-R-F>; (13)R-P-[VI]-G-R-F-G-[KR]-[RS]; (14)S-A-[LM]-A-R-F-G-[KR]-[RS]; 
(15)[PQ]-[HL]-[LMFY]-R-G-R-F-G-R; (16 )[STNFYH]-[LQ]-PQ-R-F-G-[KR]-{LC}; (17)F-M-[NH]-F-G-
K-R; (18)[AGNQ]-[GLE]-P-[LI]-R-F-G-[KR]-{QLIVMAG}; (19)P-[RK]-P-L-R-F-G>; (20)[FL]-G-T-M-R-
F-G-[KR]-[RS]; (21)Q-[WL]-[LMIV]-[AGKRST]-G-R-F-G-[KR]; (22)[GA]-[GA]-[FY]-[ST]-[FY]-R-F-G-
[RK]; (23)[GA]-[GA]-F-[ST]-[FY]-R-F>; {214,605,2}; {Q7YWT6, Q622X3,Q61P51, Q616K2, Q613X6, 
Q21656, P34405, Q60ZQ9, Q618S3, Q620F8, Q620P9, Q7PUD4, Q618T6, Q705J7, Q3SXL4, Q3KNG4, 
Q60YH4, Q622X1, Q28Z02, Q297C5, Q28Z02} 
(12) Neuropeptide-like protein* (1) G-M-Y-G-G-[FYW]-G-R; (2) A-Q-[FW]-G-Y-G-[GY]-x(2)-
[KRFYG]; (3) G-[FYW]-G-G-Y-G-G-Y-G-R-G; (4) P-L-Q-F-GK-R; (5) [STRIV]-M-S-F-G-K-R; (6) 
[AGIV]-M-[AG]-F-G-K-R; (7) [DE]-K-R-G-G-A-R-A-[FYLIVM]; (8) R-x-G-[FML]-R-PG-K-R; (9) 
[RFYM]-[AGTR]-F-A-F-A-K-R; {33, 84, 7}; {Q60NA1, Q619H9, Q624T4, Q61BN3, Q627I5, Q60MJ8, 
Q625G9, Q622L1, Q622L2} 
(13) Wamide neuropeptides* (1) [QRKED]-{P}-[KRPQN]-[IVP]-G-[LM]-W-G-R-[RDESA]; (2) 
[ANPRKQ]-x-[AGLQP]-[RHKLIVP]-G-[LM]-W-G-K-R; (3) K-[KR]-x(1,5)-W-x(6)-W-G-[KR]-R; {10, 86, 
1} {Q7Q4X3, Q8T3G1, Q60TK2, Q2LZG9} 
(14) Thyroliberin (1)[KR]-[HKR]-Q-H-P-G-[KR]-R; {12, 78, 1} 
(15) Neurotensin/neuromedin N (1)[KR]-[IVTRK]-P-Y-I-L-K-R; (2) [KR]-[IVTRK]-P-Y-I-L>; {14, 24, 0} 
(16)Allatostatin* (1) [KR]-R-{NCKRFY}-x(0,11)-[FY]-[DENAGST]-[FY]-G-[LIVM]-G-[KR]-R; (2) 
<x(0,11)-[FY]-[DENAGST]-[FY]-G-[LIVM]>; (3) [KR]-R-x(0,3)-[FY]-[DENAGST]-[FY]-G-[LIVM]>; {52, 
222, 3}; {Q7QAG2, Q29BZ8} 
(17) Egg-laying hormone (1) K-R-R-[LIVM]-R-F-[HNY]-[KR]-R; (2) P-R-[LIVM]-R-F-[HNY]-
[PSTDEN]-x-[KRG]-[KR]-[KR]; (3) P-R-[LIVM]-R-F-[HNY]-[PSTDEN]-x(1,2)>; {21, 32, 2} 
(18)Periviscerokinin (1)<x(0,1)-[AG]-x(0,3)-[GS]-[LIVM]-[LIFY]-x-[FYAMV]-[AGPM]-R-x>;{59, 59, 0} 
(19) Somatostatin (1) C-[KRM]-[NSIV]-[FY]-[FY]-W-[KRDE]-[STG]-x-[ST]-x-C; {71, 71, 2} 
(20) Orcokinin* (1) [KR]-R-N-F-[DE]-[DE]-[IV]-[DE]-[KR]; (2) <N-F-[DE]-[DE]-[IV]-[DE]-[KR]; {3, 22, 
0}; {Q7Q025, Q7QNH4, Q9W1F8, Q292P8} 
(21) Allatotropin* (1)N-x(4)-[STIV]-A-R-G-[FY]-G-[KR]-R; (2)N-x(4)-[STIV]-A-R-G-[FY]>; {15, 18, 1}; 
{Q7QKW9, Q7PZX1} 
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(22) Ghrelin and Motilinrelated peptide (1) G-[STL]-[ST]-F-[LIVM]-[ST]-P-x(0,1)-[AGSTDE]-
[FYQHM]-[QRK]; (2) [FY]-[VILM]-P-x-[FY]-[TS]-x(2)-[DE]-[LIVM]-[QRK]-[RK]-x-[QRK]-[ED]-[KR]; 
{68, 68, 12} 
(23) ADM (1) [AG]-C-{P}-x-[AGFY]-[STMLIV]-C-[AGQIVT]-[VMLIFYHKR]-[QH]-x-[LIVM]; {23, 23, 
1}; {Q4RDH7, Q6IFS9} 
(24) Hepcidin* (1) C-[CGW]-x-C-C-{C}(4,5)-[CG]-G-x-C-C; {44, 44, 1}; {Q4RUL1, Q4RUL2} 
(25) Achatin* (1) K-R-G-F-[AGF]-[DG]-K-R; (2) <G-F-[AGF]-[DG]>;  {5, 20, 0} 
(26) Cocaine- and amphetamineregulated transcript protein (1) C-x-C-x(5)-C-x(3)-[LIVM]-L-K-[C>]; 
{11, 11, 2}; {Q4RMR3, Q568S2, Q68EU1, Q4SGG2, Q4T695, Q4TBI3} 
(27)Bradykinin (1) P-[PAT]-G-[FW]-[ST]-P-[FL]-R; {58, 84, 7}; {Q5XJ76} 
(28) GBP/PSP1/paralytic (1) N-[FY]-x(2)-[GA]-C-x(2)-[GA]-[FY]-x-[RK]-[TS]-x-[DE]-[GA]-[RK]-C-
[KR]-x-[TS]; {18, 18, 0} 
(29) Stanniocalcin (1) C-L-x(2,6)-[GA]-C-x(2,5)-F-x-C-x(4)-[ST]-[CS]; {45, 45, 1} 
(30) Resistin (1) C-x-C-x(3)-C-x(2)-W-x(7)-C-x-C-x-C-x(4)-W-x(4)-C-C; {22, 22, 2} 
(31) Pro-MCH (1) [RK]-R-x(2,6)-[LMIV]-x-C-[MLIV](2)-[GA]-[RK]-[VLIM]-[FY]-x(2)-C-W; (2) R-[ED]-
x(2)-[DE](3)-N-[ST]-[AG]-x-[FY]-[PK]-[IV]-[GD]-[RK]-R; {29, 39, 4} 
(32) Pigment dispersing hormone (1) K-R-N-[ST]-[DEGA]-[LIVM](2)-N-[STAG]-[LIVM](2); (2) <N-
[ST]-[DEGA]-[LIVM](2)-N-[STAG]-[LIVM](2); {21, 21, 1}; {Q298P6} 
(33) Orexin (1) [HQ]-A-A-G-[IV]-L-T-[LIVM]-G-[KR]-R; (2) [HQ]-A-AG-[IV]-L-T-[LIVM]>; {11, 18,  0} 
(34)Leucokinin* (1) [PQAGSTKRH]-x-F-[HYN]-[AGSP]-W-[GA]-G-K-R; (2) <x-[PQAGSTKRH]-x-F-
[HYN]-[AGSP]-W-[GA]>; {11, 11, 0}; {Q60MR3, Q8MNU5} 
(35)Myomodulin* (1) [LIVM]-[HQPST]-M-L-R-L-G-K-R; {3, 29, 0} 
(36)Nitrophorin (1) C-[ST]-x(9,10)-[KRH]-x(2)-[FYW](2)-x(3,4)-[FYW](2)-x-[TS]-x-[FY]-x(4,5)-[PTS]; 
{11, 11, 1} 
(37)Prokineticin (1) Q-C-x(4)-[CFY]-C-x(2)-[ST]-x(3)-[KR]-x-[LIVM]-[RK]-x-C-x-P-x-[GA]-x(2)-[GA]-
x(2)-C-[HYF]-P; {35, 35, 1} 
(38) Leptin (1)L-x-[VIT]-[FY]-[QRH]-[QKA]-[IV]-[LIVMH]-x-[SNG]-[LM]-[PHQS]; {68, 68, 13} 
Antimicrobial
(39)Bombinin (1) K-R-[LIVM](2)-G-P-[LIVM](2)-x(2)-[VILM]-[STG]-x(2)-[LIVM]-x(2)-[LIVM](2); (2) 
<[LIVM](2)-G-P-[LIVM](2)-x(2)-[VILM]-[STG]-x(2)-[LIVM]-x(2)-[LIVM](2); (3) [SG]-IG-x(0,3)-[LIV]-
x(2,7)-K-[STAGIV]-[AGFYIV]-[LIVF]-[KR]-[GAC]-[AGFYL]-[AGLVIM]-[KRN]; {59, 110, 0} 
(40) Brevinin, Dermaseptin, Aurein, Caeridin, Caerin, Dahlein, Temporin Ponericin and Uperin 
(1) <x(7)-{C}(2)-x(0,68)-C-[KSTAGLVE]-[LIVA]-[STAKYD]-[KRYGN]-[KRDESTQLG]-C>; (2) C-
[KSTAGLVE]-[LIVA]-[STAKYD]-[KRYGN]-[KRDESTQLG]-C-R-x>; (3) <[DGA]-[LIVF]-[LIVMFW]-
[DNESAGQKPLM]-[STLIVMKFAGDN]-[LVIMAGTF]-[KRAGSTVIL]-[KRHDENGASTQ]-
[LIVMAGKFYSTW]-[IVLMAGFKRH]-[AGKRHSTDENQLIV]-{W}-x(0,2)>; (4) <[DGA]-[LIVF]-
[LIVMFW]-[DNESAGQKPLM]-[STLIVMKFAGDN]-[LVIMAGTF]-[KRAGSTVIL]-
[KRHDENGASTQ]-[LIVMAGKFYSTW]-[IVLMAGFKRH]-[AGKRHSTDENQLIV]-{W}-{CP}(2)-
x(0,35)>; (5) <x(0,45)-{QAGR}-{FYLQKRST}-K-R-[DGA]-[LIVFW]-[LIVMFW]-[DNESAGQKPLFM]-
[STLIVMKFAGDN]-[LVIMAGTFY]-[KRAGSTVIL]-[KRHDENGASTQ]-[LIVMAGKFYSTW]-
[IVLMAGFYKRH]-[AGKRHSTDENQLIV]-{W}-x(0,37)>; (6) <x(0,1)-[FIVLM]-[LIVMFYST]-[PGAQ]-
x-[LIVMFY]-[AGSTIVLM]-[KRSTNDEMLIV]-[LIVMAGFY](0,1)-[LIVMAG](0,1)-x(0,2)-[GKRDEST]-
[LIVM](2)>; (7) K-R-[FIVLM]-[LIVMFYST]-[PGAQ]-x-[LIVMFY]-[AGSTIVLM]-[KRSTNDEMLIV]-
[LIVMAGFY](0,1)-[LIVMAG](0,1)-x(0,2)-[GKRDEST]-[LIVM](2)-G-K>; {278, 310, 25} 
(41) Dermorphin (1) K-R-Y-A-F-x-[YVLI]-[PVILM]-x-[RG];(2) <Y-A-F-x-[YVLI]-[PVILM]-x>; {6, 22, 0} 
(42)Termicin* (1) C-x(4)-C-W-x(2)-C-x(12)-C-x(4)-C-x-C; {21, 21, 0} 
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(43)Liver-expressed antimicrobial (1) [KR]-P-x(4)-C-x(5)-C-x(3)-[LIVM]-C-[KR]-x(2)-[RKHQ]-[CQ]; 
{15, 15, 0}; {Q4SXZ9, Q5M9I7} 
(44) Penaeidin (1) [CR]-x(1,3)-C-{C}(2)-[LIVM]-{C}(7)-[CYF]-[CST]-{C}(3)-[GA]-x-C-C; {40, 40, 0} 
(45) Ceratotoxin* (1) [ST]-[LIVM]-[GA]-[ST]-[AG]-x-[KR]-[KR]-[AG]-[LIVM]-P-[LIVM]-[AG]-[KR](2); 
{10, 10, 3} 
(46)Attacin (1) [GTS]-[AGVMLI]-[AGFYST](0,1)-[FYLIV]-[AGDEL]-{GMQWKRHNDE}-{PKR}-
[NKG]-[ADENHIV](0,1)-[NDEKR](0,1)-[GSR]-[HFL]-[GAS]-[GAL]-[STAED]-[LIVM]-[TSMQ]-
[KRHDNEGA]-[TSEAG]-[HKRQGT] (2) Y-x-Q-[KRH]-L-[PG]-G-P-Y-G-N-S-x-P; {50, 50, 1}; {Q290V6, 
Q291C0, Q295K8, Q29QF8, Q29QG5} 
(47)Beta-defensin (1) <x(0,79)-{WP}-x-C-{C}-{CP}-{CW}-{CA}-{C}(0,4)-C-{CP}-{C}-{CW}-{C}(0,2)-C-
{C}(3)-{CP}(2)-{C}(2)-{CP}-{C}(1,5)-C-{C}(0,3)-{C}(4)-C-C-{CDENFWYP}-x(0,128)>; {326, 326, 13}; 
{Q32P86, Q2XXN6, Q2XXN7, Q2XXN8, Q2XXN9} 
(48) 4 kDa defensin* (1) G-[CGA]-P-x(2)-[HQP]-x(2)-[CRK]-[DE]-x-[HP]-[CRWK]-[KR]-G-
[MLIVEDN]; {27, 27, 0} 
Toxin
(49)Conotoxin scaffold III/IV, muconotoxin and M conotoxin (1) <x(0,62)-{C}-x(2)-{C}(10)-C-C-
{C}(2,6)-C-{C}(2,5)-C-{C}(1,5)-C-{C}(0,3)-C-{C}(0,3)>; (2) <{C}(0,9)-C-C-{C}(2,6)-C-{C}(2,5)-C-{C}(1,5)-
C-{C}(0,1)-C-{C}(0,3)>; {62, 62, 0} 
(50)Conotoxin scaffold IX and tau conotoxin (1) <x(0,49)-{C}(12)-{CDEFY}-{C}(2)-C-C-{C}(4,7)-C-
{C}(0,2)-C-{C}(0,9)>; (2) <{C}(0,14)-C-C-{C}(4,7)-C-{C}(0,2)-C-{C}(0,9)>; {80, 80, 1} 
(51)Conotoxin scaffold VI/VII, four-loop conotoxin, Spider potassium channel inhibitory toxin, O 
superfamily (1) <x-{PA}-x(0,17)-{C}(0,21)-{C}(2)-{CQ}-{C}(11)-{CI}-{CP}-{C}-{CH}-C-{C}(3,6)-C-{QC}-
{C}(3,9)-C-C-{C}(2,8)-C-{CQ}-{C}(2,9)-C-{C}(0,9)>;(2)<{C}(0,16)-{CQ}-C-{CI}-{C}(2,5)-C-{QPC}-{C}-
{CY}(2)-{C}(0,6)-C-C-{C}(2,8)-C-{CQ}-{C}(2,9)-C-{C}(0,9)>; (3) <C-{CI}-{C}(2,5)-C-{QPC}-{C}-{CY}(2)-
{C}(0,6)-C-C-{C}(2,8)-C-{CQ}-{C}(2,9)-C-{C}(0,9)>; {408, 408, 25} 
(52) Scorpion toxin (1) [CKDEN]-{C}(3)-[CI]-{CDEN}-{C}(2)-C-{C}(3)-C-{C}(6,10)-G-{C}(1,2)-[CF]-x-
{C}(3,11)-C-[WYF]-C; (2) [CKDEN]-{C}(3)-[CI]-{CDEN}-{C}(4,9)-C-{C}(3)-C-{C}(6,10)-G-{C}(1,2)-[CF]-
x-{C}(3,11)-C-[WYF]-C; {223, 223, 14}; {Q2TSD9} 
(53) Scorpion short toxin 2 (1) C-x-P-C-x(10)-C-x(2)-C-C-x(5,7)-C-x(2,3)-Q-C-LIVM]-C; {14, 14, 0} 
(54) Anenome neurotoxin (1) C-x-C-{C}(4)-P-x(6,8)-G-x(5,13)-C-x(6,9)-C-x(6,9)-C-C; {25, 25, 0} 
(55) Melittin (1) [LIVM]-[GA]-x(2)-[LIVM]-[KR]-[LIVM]; (2)-x(3)-[LIVM]-P-x-[LIVM](2)-x-W-
[LIVM]; {11, 11, 0} 
Table 2. The novel conserved peptide patterns. 
Note: each family is described in the following items: (1) the name of the family; (2) all 
identified patterns; patterns marked with ‘identical’ are completely identical to their 
PROSITE counterpart and the ones marked as ‘new’ are novel to PROSITE in Table 1; (3) the 
number of true positive peptide or precursor proteins, the number of matches to the pattern, 
and the number of false negative hits, all these numbers are in a bracket; (4) if there are 
novel putative peptides or precursors predicted by the patterns of the family, they are listed 
in a second bracket. 
6. Case study 
Patterns respectively representing the family of opioid and POMC-derived peptides as well 
as the FMRFamide and related neuropeptides (FARPs) are here shown as test cases in order 
to provide insights into the conserved sequence characteristics in many know peptide 
families and how the peptide patterns deduced based on these characteristics perform.  
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6.1 Opioid and POMC-derived peptides 
The family includes subfamilies of opioid peptides and pro-opiomelanocortin (POMC) 
proteins, and proteins in this family vary in length ranging from large precursors with a few 
hundred amino acids, e.g. Q805B5 in Chimaera phantasma (325aa), to short peptides or partial 
sequence fragments, e.g. Q7M2Z6 in Sheep (13aa). 
6.1.1 The subfamily of opioid peptides 
Opioid peptides are neuropeptides that are involved in pain control mechanisms in 
vertebrates, and they consist of proenkephalin (PENK), nociceptin (PNOC) and 
prodynorphin (PDYN) (Comb et al., 1982). The 41-column PROSITE pattern PS01252 ‘C-
x(3)-C-x(2)-C-x(2)-[KRH]-x(6,7)-[LIF]-[DNS]-x(3)-C-x-[LIVM]-[EQ]-C-[EQ]-x(8)-W-x(2)-C’ 
matches 39 Uniprot proteins. However, 92 remaining sequences from the subfamily are 
disregarded; including nine full peptide precursors e.g. zebrafish Q7T3L0 and 83 peptides or 
sequence fragments e.g. human Q9BYY3.  
The subfamily is also described by a 71-column Pfam motif PF01160. When querying this 
motif against all proteins in the subfamily by means of ‘both global (ls) and fragment (fs)’ 
search modes (http://www.sanger.ac.uk/Software/Pfam/search.shtml), 78 precursors are 
singled out. But, the other 53 opioid proteins, e.g. cat Q28409, zebrafish Q8AX66 and 
Q9W687 from Acipenser transmontanus, cannot be recognized by the Pfam motif with a score 
higher than a gathering threshold. 
A further investigation into the proteins missed by the Pfam motif is conducted by 
comparing them with all proteins in the non-redundant protein sequence database nr using 
BLAST (http://www.ncbi.nlm.nih.gov/BLAST). The alignments with Q28409 (Fig. 2) reveal 
that, while the similarities between the two Mammal precursors Q28409 and P01210 are 
conserved along the entire sequences, the resemblances between Q28409 and 
Q8AX66/Q4RIZ7 from the remote phylum of Actinopterygii are confined to a limited region 
identified as ‘[KR]-[KR]-Y-G-G-F-[ML]-[KR]-[KR]’. The few highly conserved amino acids 
are also observed from the alignments between Q9W687 and Q5Y3C6 from Chondrichthyes 
and Q6SYA7 from Dipnoi (Fig. 3). However, this conserved region is too short to produce a 
significant score, and therefore BLAST comparison alone will fail to detect the limited 
similarity preserved among the distant homologues with a critical confidence level. 
The existing PROSITE pattern and the Pfam motif both characterize only the conserved N-
terminal region of the peptide precursors, they are thus not sufficient in identifying all short 
bioactive opioid peptides or sequence fragments which are cleaved from their large 
precursors and do not carry the N-terminal part of the proteins, but nevertheless bring the 
crucial conserved peptide sequence region with them and preserve the fundamental 
function of the peptide subfamily. Therefore, although the sequences, e.g. Q28409, Q8AX66 
and Q9W687, cannot be identified by the existing motifs, they all share the pattern ‘[KR]-
[KR]-Y-G-G-F-[ML]-[KR]-[KR]’ from our ‘PeptideMotif’ database. The pattern, which is 
derived from the bioactive peptide sequences, could be more functionally conserved and 
more performable in identifying opioid peptides or entire precursor proteins.  
6.1.2 The subfamily of POMC-derived peptides 
The subfamily shares similar peptide sequences with opioid precursors, but also contains 
other non-opioid peptides such as ACTH and alpha-MSH, which are involved in the stress 
response and stimulate corticosteroid release (Arends et al., 1998). 
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Fig. 2. Sequence alignments between Q28409 and P01210/Q8AX66/Q4RIZ7 by BLAST. 
Notes: the conserved opioid peptide sequence similarities are in bold. 
No signature represents the subfamily in PROSITE; three Pfam motifs explain the proteins 
including PF08384 (45 columns), PF00976 (41 columns) and PF08035 (31 columns). These 
motifs capture separate conserved regions located respectively at the N-ternimus of the 
precursors after the removal of the signal peptide, at the sequences coding for ACTH and 
for ‘beta-endorphin’ peptides. However, the remaining parts of the precursors encoding for 
peptides of gamma-MSH (12aa) and beta-MSH (17aa) are left untouched. As a result, 27 
mature peptides or sequence fragments, e.g. Q9PRN3 from the Sea lamprey, horse P01202 
and leech P41989, cannot be detected by any of these Pfam motifs. 
Query=Q28409|PENK_FELCA Proenkephalin A-Felis silvestris catus(Mammalia) Length=187 
 
> P01210|PENK_HUMAN  Proenkephalin A precursor - Homo sapiens (Mammalia) 
Length=267   Score =  429 bits (1004),  Expect = 1e-118 
 
Query  WETCKEFLKLSQLEIPQDGTSALRESS-PEESHALRKKYGGFMKRYGGFMKKMDELYPQE   
       WETCKE L+LS+ E+PQDGTS LRE+S PEESH L K+YGGFMKRYGGFMKKMDELYP E 
Sbjct  WETCKELLQLSKPELPQDGTSTLRENSKPEESHLLAKRYGGFMKRYGGFMKKMDELYPME   
 
Query  PEEEAP-AEILAKRYGGFMKKDAEEEEDALASSSDLLKELLGPGETETAAAPRGR-----   
       PEEEA  +EILAKRYGGFMKKDAEE+ D+LA+SSDLLKELL  G+       R R      
Sbjct  PEEEANGSEILAKRYGGFMKKDAEED-DSLANSSDLLKELLETGDN------RERSHHQD   
 
Query  ---DDEDVSKSHGGFMRALKGSPQLAQEAKMLQKRYGGFMRRVGRPEWWMDYQKRYGGFL   
       ++E+VSK +GGFMR LK SPQL  EAK LQKRYGGFMRRVGRPEWWMDYQKRYGGFL 
Sbjct  GSDNEEEVSKRYGGFMRGLKRSPQLEDEAKELQKRYGGFMRRVGRPEWWMDYQKRYGGFL   
 
Query  KRFADSLPSDEEGESYS   
       KRFA++LPSDEEGESYS 
Sbjct  KRFAEALPSDEEGESYS   
 
> Q8AX66|Q8AX66_BRARE Proenkephalin (Fragment) - Brachydanio rerio (Actinopterygii) 
Length=216  Score =  140 bits (324),  Expect = 9e-32 
 
Query  KKYGGFMKRYGGFMKKMDELYPQEPEEEAPAEILAKRYGGFMKKDAE----EEED-----   
       KKYGGFMKR                     +E L KRYGGFMKK AE    E ED      
Sbjct  KKYGGFMKR---------------------SESLIKRYGGFMKKAAEFYGLESEDVDQGR   
 
Query  ALASSSDLLKELLGP-----GETETAAAPRGRDDED-VSKSHGGFMR-----ALKGSPQL   
       A+ ++ D+  E+L       GE E AA  R +  E+  +K +GGFMR     AL       
Sbjct  AILTNHDV--EMLANQVEADGEREEAALTRSKGGEEGTAKRYGGFMRRGGLYAL------   
 
Query  AQEA--KMLQKRYGGFMRRVGRPEWWMDYQ--KRYGGFLKRFADSLPSDEEGE   
         E+  + LQKRYGGFMRRVGRP+WW   Q  KRYGGFLKR      S E+ E 
Sbjct  --ESGVRELQKRYGGFMRRVGRPDWW---QESKRYGGFLKR------SQEQDE   
 
> Q4RIZ7|Q4RIZ7_TETNG Chromosome undetermined SCAF15040 - Tetraodon nigroviridis 
(Actinopterygii)  Length=246 Score =  123 bits (283),  Expect = 2e-26 
 
Query  KKYGGFMKRYGGFMKKMD------ELYPQEPEEEA--PAEIL------------------   
       KKYGGFMKRYGGFM + D      E +P +P+EE     EIL                   
Sbjct  KKYGGFMKRYGGFMSRRDVPEGALE-HPSDPDEEENIRLEILKILNAAAVHGSEGGGKAG   
 
Query  --AKRYGGFMKKDAEEEEDALASSSDLLKELLGPGETETAAAPRGRDDEDVSKSHGGFMR   
          KRYGGFM++ AEE     A+  DLL+ +LG                          R 
Sbjct  EEGKRYGGFMRR-AEEG----AAQGDLLEAVLG--------------------------R   
 
Query  ALKGSPQLAQEAKMLQKRYGGFMRRVGRPEW--------------WM---DYQKRYGGFL   
        LK             KRYGGFMRRVGRPEW              W    D QKRYGGF+ 
Sbjct  GLK-------------KRYGGFMRRVGRPEWLVDSSKRGGVLKRAWGSDNDLQKRYGGFM   
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Fig. 3. Sequence alignments between Q9W687 and Q5Y3C6/Q6SYA7 by BLAST. 
Note: the conserved opioid peptide sequence similarities are in bold. 
The BLAST alignment between Q9PRN3 and all proteins in the nr database unveils that, 
although Q9PRN3 cannot be identified by the Pfam motifs, it shares the highly conserved 
‘PeptideMotif’ pattern ‘Y-x-[MV]-x-H-F-R-W’ with other POMC subfamily members, e.g., 
Q2L6A9 from Hyperoartia, P01193 and Q53WY7 from Mammalia, and Q32U15 from 
Amphibia (Fig. 4). This 8-column peptide pattern is a part of the 41-column Pfam motif 
PF00976. While the sequence region, which is described by this Pfam motif, may be an entire 
functional or structural domain, this peptide pattern contained within the longer domain is 
probably the most essentially functional part. 
In total, our procedure identifies six novel peptide patterns in the combination of these two 
subfamilies. Among all the 397 proteins in this family, 113 were found to contain two of the 
peptide patterns, and the rest match one of them. These patterns characterize conserved 
domains located at different regions of a precursor sequence, and each of them can 
exclusively represent an opioid or POMC peptide or its precursor protein. 
6.2 FMRFamide and related neuropeptides (FARPs) 
It is widely known that FARPs occur throughout the whole animal kingdom and therefore 
this family is an ideally suited test case to check whether the disclosed pattern is capable of 
retrieving FARPs from all metazoan species (Ubuka et al., 2009). In total, 23 conserved 
peptide patterns have been uncovered from the family, and they match 214 FARPs 
sequences with 605 hits due to the presence of multiple copies of the conserved patterns 
within some precursor proteins. The identified FARPs distribute among a wide range of 
phyla, including Nematoda (85), Arthropoda (50), Mollusca (24), Annelida (9), 
Platyhelminthes (1), Cnidaria (10) and Chordata (35).  
An 11-column Pfam motif PF01581 characterizes FARPs from all above-mentioned phyla 
except Chordata, e.g. human Q9HCQ7 and mouse Q9WVA8. In addition, conversely to the 
‘PeptideMotif’ patterns, 49 FARP peptides or precursor proteins in these characterized 
phyla, e.g., Q9TWD2 from Lymnaea stagnalis and Q95QP2 from Caenorhabditis elegans, cannot 
be revealed by the Pfam motif with a significant score (e-value <0.01). 
Query= Q9W687|Q9W687_ACITR Proenkephalin (Fragment)-Acipenser 
transmontanus (Actinopterygii)   Length=45 
 
> Q5Y3C6|Q5Y3C6_HETPO Proenkephalin - Heterodontus portusjacksoni 
(Chondrichthyes)  Length=264 Score = 39.2 bits (85),  Expect = 0.032 
 
Query  14   RYDGFSKQ------PEHTDSKEITSEEV---EKRYGGFM  43 
            RY GF K+      P   D  EI S+EV   EKRYGGFM 
Sbjct  225  RYGGFMKRWNDILVPSDEDG-EIYSKEVPELEKRYGGFM  262 
 
Score = 31.2 bits (66),  Expect = 8.7 
 
Query  14   RYDGFSKQPEHTDSKE--ITSEEVE----------KRYGGFM  43 
            RY GF K+    DS +  I+  EV+          KRYGGFM 
Sbjct  105  RYGGFMKK---ADSGDMYIS--EVDDENKGREILSKRYGGFM  141 
 
> Q6SYA7|Q6SYA7_PROAN Prodynorphin (Fragment) - Protopterus annectens 
(Dipnoi)   Length=191 Score = 33.7 bits (72),  Expect = 1.5 
 
Query  33   EEVEKRYGGFM  43 
            EE++KRYGGFM 
Sbjct  169  EELQKRYGGFM  179 
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Fig. 4. Sequence alignments between Q9PRN3 and P01193/Q53WY7/Q32U15 by BLAST. 
Note: the conserved peptide sequence similarities are in bold. 
The Clustal-W multi-alignment of all these FARP sequences together or within each of the 
seven phyla using default parameters (http://www.ebi.ac.uk/clustalw/) shows that the 
FARP precursors display sequence similarities within the mature peptide regions, 
particularly in the area containing the conserved peptide patterns, and that the remaining 
parts of the precursor sequences display rather low similarities. The FARP peptide 
precursors also differ from each other by the number of peptide repeat units within the 
sequences, which is thought to have arisen by unequal crossover events (Lee et al., 1998). In 
addition, we also observed that most of the mature FARP peptides share common C-
terminal sequences but have much mutated N-terminal extensions. All these make it 
problematic to construct an accurate multiple alignment in order to derive a statistical 
 
Query= Q9PRN3|Q9PRN3_PETMA Melanotropin MSH-B - Petromyzon marinus 
(Hyperoartia)  Length=20 
 
> Q2L6A9|Q2L6A9_MORMR Proopiomelanotropin (Fragment) - Mordacia mordax 
(Hyperoartia)  Length=154 Score = 51.5 bits (114),  Expect = 5e-06 
 
Query  2   QESADGYRMQHFRWGQPLP  20 
           QE+ D YR+QHFRWG+PLP 
Sbjct  11  QENPDAYRIQHFRWGEPLP  29 
 
> P01193|COLI_MOUSE Corticotropin-lipotropin precursor(Pro-
opiomelanocortin) (POMC) - Mus musculus (Mammalia)  Length=235 
Score = 32.5 bits (69),  Expect = 2.4 
 
Query  8    YRMQHFRWGQP  18 
            Y M+HFRWG+P 
Sbjct  125  YSMEHFRWGKP  135 
 
Score = 30.8 bits (65),  Expect = 7.7 
 
Query  3    ESADG-YRMQHFRWGQP  18 
            E  DG YR++HFRW  P 
Sbjct  183  EKDDGPYRVEHFRWSNP  199 
 
Score = 22.3 bits (45),  Expect =  2753 
 
Query  8   YRMQHFRW  15 
           Y M HFRW 
Sbjct  77  YVMGHFRW  84 
 
> Q53WY7|Q53WY7_HUMAN Proopiomelanocortin (Fragment) - Homo sapiens 
(Mammalia)  Length=30 Score = 22.3 bits (45),  Expect =  2753 
 
Query  8   YRMQHFRW  15 
           Y M HFRW 
Sbjct  3   YVMGHFRW  10 
 
> Q32U15|Q32U15_9NEOB Proopiomelanocortin A (Fragment) - Trachycephalus 
jordani (Amphibia)  Length=82 Score = 23.1 bits (47),  Expect =  1529 
 
Query  8   YRMQHFRW  15 
           Y M HFRW 
Sbjct  23  YVMSHFRW  30 
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model which represents distantly related proteins from various phyla throughout the 
evolutionary history of the FARP peptide family. 
7. Conclusion 
Protein domains are highly conserved throughout evolution and there are several databases 
available that catalogue protein families and domains. Such motif and domain databases are 
very useful in assigning a putative function to an unknown protein. Peptide precursor 
proteins are a distinctive class of molecules because they undertake various 
posttranslational modifications in order to ultimately synthesize stabilized and functional 
mature peptides, making the annotation of peptides and peptide precursor proteins 
challenging. This is illustrated by the fact that many metazoan peptides and peptide 
precursors are not represented by the motifs currently present in the widely used motif 
database such as PROSITE. 
Because of the tremendously increasing number of protein sequences and because of the 
wide range of peptide families, a comprehensive database of conserved patterns typical for 
endogenously occurring mature peptides is of great value in identifying new peptides and 
precursor proteins to catch up with their sequencing rate. We therefore have designed a 
searching procedure to find conserved patterns within the known peptides, and as a result, 
we have constructed a ‘PeptideMotif’ database that is representative of most currently 
known peptide families.  
Many peptides have been isolated and sequenced as mature peptides and their precursor 
proteins are often unknown as yet. Therefore, these small peptides are difficult to be 
identified by other motif databases. Motifs in databases such as Pfam contain two Hidden 
Marcov Models (HMMs) for each family based on a multiple protein sequence alignment, 
one built to find complete domains (ls mode) and the other to match fragments of 
domains (fs mode) (Durbin et al., 1998). These motifs are sensitive at identifying complete 
domains and thus they can efficiently detect the proteins which have similarities that 
cover the full length protein sequence or at least contain a complete domain. However, 
these motifs do not work very well when they encounter short peptides which lack 
information on amino acids at the sites outside the peptide sequences, or when the 
conserved regions are limited, especially in distantly related proteins where the overall-
length sequence similarity may be not well preserved. In contrast, the patterns derived 
directly from the mature peptide sequences grasp the highly preserved region of the 
precursor proteins and thus are able to identify not only the peptide precursor molecules 
but also the fully processed peptides. 
Conservative peptide sequence patterns correspond to functionally and structurally 
important parts of the peptides, i.e. the binding site to specific receptors, the disulphide 
bonds for stability and tertiary structure. The discovery of peptide motifs will be 
undoubtedly of great value for any peptide-related studies ranging from the identification 
of putative peptides and precursor proteins to the annotation of critical functional 
residues (Husson et al., 2010), to the complement of peptidomic research in detecting and 
verifying peptides in vitro (Baggerman et al., 2004; Boonen et al., 2008; Menschaert et al., 
2010). For example, scanning the peptide patterns against Uniprot revealed 95 proteins 
(listed in Tables 1 and 2) which are not as yet annotated as putative peptides or precursor 
proteins. 
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When determining short functional patterns for peptide sequences, we have to evaluate how 
representative the peptide motifs are in the 110 characterized peptide families. Short motifs 
often have some degree of degeneracy and the presence of a motif in a protein may reflect a 
conserved functional role, a yet to be discovered structural functional role or a non-
functional role. When using the short currently identified peptide patterns, while the false 
positives are kept to zero, we observe that 440 (3.8%) of the mature peptides or sequence 
fragments and 282 (2.5%) of the peptide precursor proteins in these described families 
cannot be recognized by the peptide patterns. Many of them could be determined by 
combining the peptide pattern search procedure with the structural hallmarks of bioactive 
peptides and their precursors (Liu et al., 2006), such as the length of a peptide precursor 
which is usually not longer than 500 amino acids, the presence of a signal peptide which 
directs a precursor protein into the secretary pathway of the cell, and the presence of typical 
cleavage sites flanking the mature peptides. To be even more successful in identifying all 
false negatives while eliminating all false positives because of the short length and 
degeneracy of most short motifs, it may be possible to make use of 3D structural patterns 
when they become available for peptide precursor proteins. Patterns that integrate 3D 
structural information of the sequences will be more sensitive in identifying peptides and 
peptide precursors (Gribskov et al., 1988; Taylor et al., 2004). 
While the majority of known peptide families have been profiled by the established peptide 
patterns, the remaining ones accounting for in total 251 peptides and precursor proteins (2% 
of all the proteins in the peptide-precursor database) are not processed by the pattern search 
procedure. They are from small peptide families, such as eclosion hormones, ecdysis-
triggering hormones and apelin, which have only a few homologies so far. A pattern based 
on the small number of peptides usually cannot gain enough confidence in representing the 
family, and also cannot sufficiently reflect the sequence divergence accumulated in the 
evolutionary course of the family member. As more peptides and precursor proteins are 
sequenced, our patterns search procedure can be applied to the corresponding families and 
the ‘PeptideMotif’ database will be updated accordingly, keeping the peptide pattern 
database widely applicable for the identification of critical functional residues and for the 
annotation of hypothetical molecules in various peptide families. 
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